DABA Biotech Limited is revolutionising the biotechnology sector by fostering innovation, boosting global competitiveness and ...

Olin (NYSE:OLN – Free Report) had its target price decreased by UBS Group from $34.00 to $21.00 in a research note published on Monday,Benzinga reports. UBS Group currently has a neutral rating on the ...

Olin (NYSE:OLN – Free Report) had its price objective trimmed by Piper Sandler from $33.00 to $26.00 in a research note issued to investors on Monday,Benzinga reports. The firm currently has a neutral ...